PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
92.26%
Net income growth under 50% of CSIQ's 991.20%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-97.69%
Negative yoy D&A while CSIQ is 23.60%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-100.00%
Negative yoy deferred tax while CSIQ stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-73.52%
Both cut yoy SBC, with CSIQ at -100.00%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-98.91%
Both reduce yoy usage, with CSIQ at -2576.91%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-73.45%
Both yoy AR lines negative, with CSIQ at -100.00%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-88.44%
Both reduce yoy inventory, with CSIQ at -100.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-24.95%
Negative yoy AP while CSIQ is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-105.01%
Both reduce yoy usage, with CSIQ at -2294.80%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
54.51%
Well above CSIQ's 69.06%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
82.45%
Some CFO growth while CSIQ is negative at -252.54%. John Neff would note a short-term liquidity lead over the competitor.
95.10%
CapEx growth well above CSIQ's 8.21%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Purchases growth of 100.00% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-100.00%
We reduce yoy sales while CSIQ is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-285.61%
We reduce yoy other investing while CSIQ is 138.08%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
96.23%
Investing outflow well above CSIQ's 12.90%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-108.96%
We cut debt repayment yoy while CSIQ is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Buyback growth of 100.00% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.